Samsung Pharmaceutical

삼성제약 · 001360

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$98.4M (₩135.8B)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$33.4M

▲ +4.0% YoY

Operating profit · FY2025

−US$13.1M

Loss widened

Net income · FY2025

US$8.4M

Turned profitable

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$37.6M(₩52B)	US$32.1M(₩44.3B)	US$33.4M(₩46.1B)
Operating profit	−US$13.1M(−₩18B)	−US$10.7M(−₩14.8B)	−US$13.1M(−₩18.1B)
Net income	−US$18M(−₩24.8B)	−US$10.2M(−₩14.1B)	US$8.4M(₩11.5B)

Revenue

Operating profit

Net income

ROE

9.5%

Debt/Eq

38.3%

Op. margin

-39.2%

Net margin

25.1%

Rev. YoY

▲ +4.0%

Interactive price history isn't here yet. Would you use it?